The Anaesthesia & Respiratory Devices Market size in the Asia Pacific was worth USD 4.12 billion in 2020. It is further estimated to be growing at a CAGR of 9.61% and worth USD 6.52 billion by 2025.
Rise in the number of people with respiratory ailments like COPD, asthma, sleep apnoea, and other such disorders, technological advancements in the device design, boost in IT and software for improvement in the devices' performance, growth in the geriatric population, increase in environmental pollution. Rising demand for telemedicine is the major factor driving the anesthesia and respiratory devices market.
Increasing alternative therapies are a key constrain for the market.
This research report on the Asia Pacific Anaesthesia and Respiratory Devices Market segmented and sub-segmented into the following categories.
By Device:
By Region:
The Asia Pacific is expected to have the highest growth rate during the forecast period. Manufacturers of anesthesia and respiratory devices are continuously making efforts to upgrade their technology to produce better products. Over the past few years, people's choice has shifted from hospital care to home health care services. This has encouraged top players to bring in varieties of portable medical devices. The accessibility of a variety of home healthcare devices has propelled the global market in the recent past.
Companies like Philips Healthcare, OSI Systems, Mindray, GE Healthcare, Draegerwerk AG, Masimo, Getinge Group, Fisher and Paykel, Covidien, Airsep Corp, Alung Technologies Inc, Bomimed Inc, 3M, Carefusion Inc, Astra Zeneca, Invacare, ResMed, Teleflex Inc, and Smiths Medical are dominating the APAC Anaesthesia and Respiratory Devices Market.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device
5.1.1 Introduction
5.1.2 Anaesthesia Devices
5.1.2.1 Anaesthesia Machines
5.1.2.2 Anaesthetic Monitors
5.1.2.3 Anaesthetic Vaporizers
5.1.2.4 Analgesic Machines
5.1.2.5 Anaesthetic Masks
5.1.2.6 Anaesthetic Accessories
5.1.3 Respiratory Devices
5.1.3.1 Humidifiers
5.1.3.2 Resuscitators
5.1.3.3 Breathing Circuits
5.1.3.4 Chambers
5.1.3.5 CPAP Devices
5.1.3.6 Masks
5.1.3.7 Oxygen Concentrators
5.1.3.8 Nebulizers
5.1.3.9 Ventilators
5.1.3.10 Inhalers
5.1.3.11 Tracheotomy Tubes
5.1.3.12 Oxygen Cannula
5.1.3.13 Capnographs
5.1.3.14 Spirometers
5.1.5 Y-o-Y Growth Analysis, By Device
5.1.6 Market Attractiveness Analysis, By Device
5.1.7 Market Share Analysis, By Device
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Device
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Device
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Philips Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 OSI Systems and Mindray
8.3 GE Healthcare
8.4 Draegerwerk AG
8.5 Masimo
8.6 Getinge Group
8.7 Fisher and Paykel
8.8 Covidien
8.9 Airsep Corp.
8.10 Alung Technologies Inc.
8.11 Bomimed Inc.
8.12 3M
8.13 Carefusion Inc.
8.14 Astra Zeneca
8.15 Invacare
8.16 ResMed
8.17 Teleflex Inc.
8.18 Smiths Medical
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
